The landscape of obesity treatment is changing dramatically with the emergence of several novel injectable therapies. Tirzepatide , Cagrilintide , a GLP-1/GIP/GCG triple agonist , and a GLP-1 receptor agonist https://nexaphresearchpeptides.com/product-category/recovery-peptides/